BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6218563)

  • 1. Moxalactam: an oxa-beta-lactam antibiotic that inactivates beta-lactamases.
    Labia R
    Rev Infect Dis; 1982; 4 Suppl():S529-35. PubMed ID: 6218563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Moxalactam: an inactivator of beta-lactamases].
    Labia R
    Sem Hop; 1983 Jun; 59(26):1959-62. PubMed ID: 6310786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro activity and beta-lactamase stability of moxalactam and other selected cephalosporin antibiotics.
    Vuye A
    Arzneimittelforschung; 1981; 31(8):1290-5. PubMed ID: 6457607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro evaluation of moxalactam on enterobacteria producing beta-lactamases].
    Kazmierczak A; Pechinot A; Duez JM; Kohli E; Tremeaux JC
    Sem Hop; 1983 Jun; 59(26):1953-7. PubMed ID: 6310785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of moxalactam to beta-lactamase.
    Richmond MH
    Rev Infect Dis; 1982; 4 Suppl():S522-6. PubMed ID: 6218561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparative beta-lactamase resistance and inhibitory activity of 1-oxa cephalosporin, cefoxitin and cefotaxime.
    Fu KP; Neu HC
    J Antibiot (Tokyo); 1979 Sep; 32(9):909-14. PubMed ID: 315938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity of cefmenoxime for beta-lactamases: an analysis.
    Labia R; Morand A; Verchere-Beaur C; Bryskier A
    Am J Med; 1984 Dec; 77(6A):25-7. PubMed ID: 6097119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of cefdinir with beta-lactamases.
    Labia R; Morand A
    Drugs Exp Clin Res; 1994; 20(2):43-8. PubMed ID: 7924895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
    Baumgärtner M; Dickgiesser N; Müller S; Wundt W
    Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity and specific beta-lactamase susceptibility of cefoperazone and moxalactam. Comparison with other cephalosporins.
    Mouton RP; Bongaerts GP; van Gestel M; Bruggeman-Ogle KM
    Chemotherapy; 1981; 27(5):318-24. PubMed ID: 6455258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-lactamase stability of cefoxitin in comparison with other beta-lactam compounds.
    Neu HC
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):313-6. PubMed ID: 6321094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo antibacterial activity of moxalactam, an oxa-beta-lactam antibiotic.
    Goto S
    Rev Infect Dis; 1982; 4 Suppl():S501-10. PubMed ID: 6218559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro activity of the novel oxa-beta-lactam antibiotic moxalactam (LY 127935) against dense populations of selected Gram-negative bacilli.
    Greenwood D; Eley A; Pearson N; O'Grady F
    J Antimicrob Chemother; 1981 Apr; 7(4):353-62. PubMed ID: 6265424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials.
    Jones RN; Wilson HW
    Diagn Microbiol Infect Dis; 1983 Mar; 1(1):71-83. PubMed ID: 6323095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
    Hanslo D; King A; Shannon K; Warren C; Phillips I
    J Antimicrob Chemother; 1981 Jun; 7(6):607-17. PubMed ID: 6265426
    [No Abstract]   [Full Text] [Related]  

  • 16. Newer cephalosporins and cephamycins--a review.
    Norrby R
    Scand J Infect Dis Suppl; 1978; (13):83-7. PubMed ID: 356183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of cefotaxime and moxalactam (LY127935) against Haemophilus influenzae.
    Jorgensen JH; Crawford SA; Alexander GA
    Antimicrob Agents Chemother; 1980 Mar; 17(3):516-7. PubMed ID: 6252832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.
    Borobio MV; Aznar J; Jimenez R; Garcia F; Perea EJ
    Antimicrob Agents Chemother; 1980 Feb; 17(2):129-31. PubMed ID: 6247966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative activities of moxalactam (LY 127935) a new semisynthetic 1-oxa-beta lactam antibiotic with 7 other antibiotics against type b Haemophilus influenzae.
    Chu ML; Harms JL; Liu C
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1981 Sep; 14(3):146-55. PubMed ID: 6456875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moxalactam: the first of a new class of beta-lactam antibiotics.
    Webber JA; Yoshida T
    Rev Infect Dis; 1982; 4 Suppl():S496-500. PubMed ID: 6218558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.